Study of outcomes of prostate cancer patients treated with proton therapy
Not Applicable
- Conditions
- Health Condition 1: C61- Malignant neoplasm of prostate
- Registration Number
- CTRI/2022/01/039842
- Lead Sponsor
- Apollo Proton Cancer Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age more than 18 years
2. Patient with biopsy proven diagnosis of prostate cancer treated with proton beam at the Apollo Proton Cancer Centre.
3. Patient / guardian, who have the ability to understand and be willing to sign a written informed consent document
Exclusion Criteria
Patients or legal guardians who are not willing sign informed consent document
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method